Daré Bioscience, Inc. (DARE) Deep Dive Video

Daré is shifting from a decade-long R&D story into a women’s-health commercial platform—using royalties plus 503B “fast-to-market” launches to unlock asymmetric upside, with execution and regulatory risk as the fulcrum.